Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 80 of 88« First...102030...7879808182...Last »

OTC Dietary Supplements Sold To Minors In Many Health Food Stores, Despite Warnings

[embedded content] According to the results of a new study, teens were able to purchase potentially dangerous supplements at a variety of health food stores across the US, despite labels reading “for adult use only.” More troubling is the fact that the staff at certain stores recommended and endorsed specific products, although they were “for […]

Read More »

Advanced Proteome Therapeutics’ Lead Compound Inhibits Metastasis in Breast Cancer Tumor Model

VANCOUVER, BC–(Marketwired – April 29, 2015) – Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSX VENTURE: APC) (FRANKFURT: 0E8) is pleased to announce that its current lead compound APC 101 successfully diminished the frequency of tumor metastasis in the 4T1 animal model. The Company’s academic collaborators used three different methods, carried out over several […]

Read More »

Amgen Announces FDA Advisory Committee Meeting To Review Repatha (Evolocumab) As A Treatment For High Cholesterol

THOUSAND OAKS, Calif., April 29, 2015 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the U.S. Food and Drug Administration (FDA) will review data supporting the Company’s Biologics License Application (BLA) for RepathaTM (evolocumab) for the treatment of high cholesterol at a meeting on June 10, 2015. Repatha […]

Read More »

Philips launches innovative 3D navigation system to enhance minimally invasive treatment of vascular disease

• VesselNavigator has been designed for use in conjunction with Philips interventional X-ray systems to guide catheters during treatment of vascular disease. • Major reduction of contrast medium (70%) demonstrated in clinical study, enabling minimally invasive treatment of aortic aneurysms in the fast growing number of patients currently unable to benefit from minimally-invasive techniques. Amsterdam, […]

Read More »

Alexza Pharmaceuticals Announces Management Promotions

MOUNTAIN VIEW, Calif., April 29, 2015 /PRNewswire/ — Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced two management promotions.  Dr. Edwin S. Kamemoto has been promoted to the newly created position of Executive Vice President, R&D and Quality.  In this new role,  Dr. Kamemoto will be responsible for research and development, regulatory affairs, clinical research, pharmacovigilance, and the […]

Read More »

No Benefit For A Commonly Used Cardiac Device

Once again, after decades of common use, a frequently implanted device has been found to confer no benefit whatsoever over a much less invasive therapy. Cardiologists and radiologists often implant the device, called a retrievable inferior vena cava filter, inside people who are at high risk for developing potentially lethal blood clots. The filter is designed to prevent […]

Read More »

BIO Praises the Release of 21st Century Cures Initiative Discussion Draft

WASHINGTON–(BUSINESS WIRE)–The Biotechnology Industry Organization (BIO) today releases the following statement on the 21st Century Cures Initiative discussion draft shared by Chairman Fred Upton (R-MI), Rep. Diana DeGette (D-CO), Rep. Frank Pallone, Jr. (D-NJ), Rep. Joe Pitts (R-PA), and Rep. Gene Green (D-TX). This statement can be attributed to Jim Greenwood, BIO President and CEO: […]

Read More »

Kids of severely obese moms have higher risk of ADHD

File photo of a woman with a child on the beach in Santa Monica, California, May 12, 2012. Reuters/David McNew (This version of the story was refiled to correct name of the researcher interviewed for this story, from Heejoo Jo to Laura Schieve; Replaces para 2; fixes paras 3, 5, 10, 13, 15, and 17.) […]

Read More »

Are Nanoparticles the New Secret Weapon Against Tooth Decay?

LOS ANGELES, April 29, 2015 /PRNewswire/ — Technological innovation and scientific discovery are critical components of healthcare that have greatly improved treatment and patient care across all fields of medicine. As medical experts and scientists continue to find new and better ways to prevent and cure maladies, patients continue to benefit from practices that are increasingly […]

Read More »

Betting On China For New Drug Development

Healthcare investment firm OrbiMed manages over $14 billion in public and private equity, nearly $1.4 billion of which is focused on Asia. With 23 private equity investments in Asia, OrbiMed is spreading its interests across the healthcare spectrum, including drugs, medical devices, services and enabling technology. Jonathan Wang, senior managing director at OrbiMed, joined the […]

Read More »

Eating sugar may fuel cravings for more by quieting stress

(Reuters Health) – Eating sugar may quiet stress signals in the brain, leading some people to seek comfort by consuming more sweets and making the habit very hard to break, a small study suggests. In a two-week experiment, 19 women drank three beverages a day sweetened either with real sugar or aspartame, a substitute. Researchers […]

Read More »

Drug That Can Prevent the Onset of Diabetes is Rarely Used

LOS ANGELES–(BUSINESS WIRE)–Few doctors are prescribing a low-cost drug that has been proven effective in preventing the onset of diabetes, according to a UCLA study. The study, published in the peer-reviewed journal Annals of Internal Medicine, found that only 3.7 percent of U.S. adults with pre-diabetes were prescribed metformin during a recent three-year period. Metformin […]

Read More »

Kids of severely obese moms have higher risk of ADHD

<span class="articleLocation”>(Reuters Health) – Six-year-olds whose mothers were severely obese before pregnancy are more likely to have developmental or emotional problems than kids of healthy-weight moms, according to a new study. The researchers had found evidence of this link in two previous studies, said lead author Heejoo Jo of the Centers for Disease Control and […]

Read More »

Merck says FDA again declines to approve Bridion, needs more data

(Reuters) – Merck & Co on Tuesday said the U.S. Food and Drug Administration has again declined to approve Bridion, its drug to reverse the effects of muscle relaxants used in surgery, until the agency receives more data on allergic reactions to the product. Roger Perlmutter, Merck’s research chief, told analysts on a conference call […]

Read More »

Strong Merck cancer drug sales upstage rival Bristol-Myers

(Reuters) – Investors betting that Bristol-Myers Squibb will emerge as the leading player in a hot new class of cancer drugs hit the pause button on Tuesday as a rival therapy from Merck & Co showed much higher sales. Bristol shares fell as much as 2.7 percent and closed off 1 percent after reporting sales […]

Read More »

Sanofi says U.S. FDA to fast track Fabry therapy review

(Reuters) – French drugmaker Sanofi said on Tuesday that the U.S. Food and Drug Administration has agreed to speed up the review of its drug application for a new Fabry disease treatment. Sanofi said its Genzyme unit was enrolling patients in a mid-stage Phase IIa trial of the “GZ/SAR402671” therapy. Fabry disease is an inherited, […]

Read More »

GSK shingles vaccine shows benefits across all age groups

(Reuters) – An experimental shingles vaccine from GlaxoSmithKline is effective across all age groups, researchers said on Tuesday, boosting the prospects of a key product in the British drugmaker’s development pipeline. In contrast to Merck’s established Zostavax, currently the only product on the market, GSK’s vaccine HZ/su showed no diminution in efficacy with age, according […]

Read More »

Bio-Path Holdings Granted Orphan Drug Designation for Liposomal Grb-2 in Acute Myeloid Leukemia

HOUSTON–(BUSINESS WIRE)–Bio-Path Holdings, Inc. (NASDAQ:BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that they have received orphan drug designation from the U.S. Food and Drug Administration (FDA) for its lead compound Liposomal Grb-2 for the treatment of acute myeloid leukemia (AML). Orphan drug status provides Bio-Path […]

Read More »

U.S.-African diet swap has dramatic impact on colon cancer risk

(Reuters) – Black Americans who switched to a high-fiber African diet for just two weeks saw a dramatic drop in risk factors for colon cancer, a study published on Tuesday found. A group of Africans who went the other way and started eating American food rich in animal proteins and fats saw their risks rise […]

Read More »

Study: Mental Health Effects Of Bullying Even Worse Than Effects Of Abuse By Adults

According to a new study, those bullied by peers often suffer even worse long-term mental health outcomes than those maltreated by adults early in life. The effects of both sorts of abuse are well-documented, but this is the first study to examine whether bullying, on its own, results in dire psychological problems later in life […]

Read More »

Page 80 of 88« First...102030...7879808182...Last »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

April 2018 Focus: Agency Profiles, Manny Awards and Annual Review

Subscribe

Ad Right Bottom

Main Navigation